291 543

Cited 0 times in

A comparison of efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection

DC Field Value Language
dc.contributor.author김남오-
dc.date.accessioned2015-12-24T09:05:16Z-
dc.date.available2015-12-24T09:05:16Z-
dc.date.issued2014-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/134927-
dc.descriptionDept. of Medicine/석사-
dc.description.abstractIntroduction: Endoscopic submucosal dissection (ESD) requires adequate sedation and pain control, for which the short acting drugs such as propofol and remifentanil are recommended. Dexmedetomidine has sedative and analgesic effects and suppresses gastrointestinal motility, which might be critical during ESD. We compared the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil for use during ESD.Method: Fifty-nine patients scheduled for ESD were randomly allocated into a dexmedetomidine-remifentanil (DR) group or a propofol-remifentanil (PR) group. To control patient anxiety, dexmedetomidine or propofol was infused to maintain a score of 4–5 on the Modified Observer’s Assessment of Alertness/Sedation scale. Remifentanil was infused continuously at a rate of 6 μg/h/kg in both groups. The ease of advancing the scope into the throat, gastric motility grading, and satisfaction of the endoscopist and patient were assessed. Hemodynamic variables and hypoxemic events were compared to evaluate patient safety.Results: Demographic data were comparable between the groups. The hemodynamic variables and pulse oximetry values were stable during the procedure in both groups despite a lower heart rate in the DR group. No desaturation events occurred in either group. Although advancing the scope into the throat was easier in the PR group (“very easy” 24.1% vs. 56.7%, P = 0.01), gastric motility was more suppressed in the DR group (“no + mild” 96.6% vs. 73.3%, P = 0.013). The endoscopists felt that the procedure was more favorable in the DR group (“very good + good” 100% vs. 86.7%, P = 0.042), whereas patient satisfaction scores were comparable between the groups. Conclusions: The efficacy and safety of dexmedetomidine and remifentanil were comparable to propofol and remifentanil during ESD. However, endoscopists favored dexmedetomidine perhaps due to lower gastric motility.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.publisherGraduate School, Yonsei University-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleA comparison of efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection-
dc.title.alternative내시경적 점막하절제술을 시행받는 환자에서 덱스메데토미딘-레미펜타닐(dexmedetomidine-remifentanil)과 프로포-
dc.typeThesis-
dc.contributor.departmentDept. of Anesthesiology and Pain Medicine (마취통증의학교실)-
dc.contributor.localIdA00356-
dc.contributor.alternativeNameKim, Namo-
dc.contributor.affiliatedAuthor김남오-
dc.type.localThesis-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 2. Thesis

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.